A US based pharmaceutical company with a global revenue of more than $400 million, specialized in generic drugs, was looking for Regulatory assistance to file ANDAs, Supplements and PADER to the agency. The objective was to review all the documents as per the FDA PDF specifications and provide compliant and valid submissions while reducing the overall turnaround time.

Download the case to know how Freyr leveraged its expertise to provide end-to-end Regulatory submission services to deliver quality submission in given time.